Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
gardasil vaccine eradicating hpv infections, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.23 |
Change
-0.670(0.22%) |
Mkt cap ! $148.2B | |||
| Open | High | Low | Value | Volume |
| $307.51 | $308.38 | $306.26 | $48.70M | 158.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 71 | $307.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.24 | 30 | 2 |
View Market Depth
| Last trade - 12.55pm 29/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |